Core Insights - OrthoPediatrics Corp. has reached a significant milestone in the Global POISE Study, with over 600 implants being observed across more than 300 pediatric patients [1][2][4] Group 1: Global POISE Study Overview - The Global POISE Study is a multi-center, post-market, prospective clinical follow-up study aimed at assessing the safety and efficacy of OrthoPediatrics' implant devices [2] - The study, launched in 2023, currently includes 13 active sites across Canada, the United States, Australia, New Zealand, and South Africa, with ongoing data collection [2][3] - The study focuses on verifying implant survival and identifying any device-related adverse events [2] Group 2: Study Impact and Future Directions - Insights from the Global POISE Study will help refine OrthoPediatrics devices to better meet the needs of children with orthopedic conditions [3] - The study aims to broaden its reach by enrolling additional patients across 17 different implant types to enhance understanding of safety and long-term effectiveness [3] Group 3: Company Background - OrthoPediatrics Corp. was founded in 2006 and focuses exclusively on pediatric orthopedics, offering over 80 products across trauma and deformity, scoliosis, and sports medicine categories [6] - The company distributes its products in the United States and over 70 countries globally, emphasizing its commitment to improving the lives of children with orthopedic conditions [6]